Found: 83
Select item for more details and to access through your institution.
Induction of human cytotoxic T lymphocytes specific for prostate-specific antigen.
- Published in:
- Prostate, 1997, v. 30, n. 2, p. 73, doi. 10.1002/(SICI)1097-0045(19970201)30:2<73::AID-PROS1>3.0.CO;2-L
- By:
- Publication type:
- Article
Enabling a Genetically Informed Approach to Cancer Medicine: A Retrospective Evaluation of the Impact of Comprehensive Tumor Profiling Using a Targeted Next-Generation Sequencing Panel.
- Published in:
- Oncologist, 2014, v. 19, n. 6, p. 616, doi. 10.1634/theoncologist.2014-0011
- By:
- Publication type:
- Article
Immune Assessment Today: Optimizing and Standardizing Efforts to Monitor Immune Responses in Cancer and Beyond.
- Published in:
- Cancers, 2024, v. 16, n. 3, p. 475, doi. 10.3390/cancers16030475
- By:
- Publication type:
- Article
New Approaches to Targeted Therapy in Melanoma.
- Published in:
- Cancers, 2023, v. 15, n. 12, p. 3224, doi. 10.3390/cancers15123224
- By:
- Publication type:
- Article
The Janus Face of IL-33 Signaling in Tumor Development and Immune Escape.
- Published in:
- Cancers, 2021, v. 13, n. 13, p. 3281, doi. 10.3390/cancers13133281
- By:
- Publication type:
- Article
The "Great Debate" at Melanoma Bridge 2020: December, 5th, 2020.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Combination Immunotherapy: An Emerging Paradigm in Cancer Therapeutics.
- Published in:
- Oncology (08909091), 2015, v. 29, n. 12, p. 1005
- By:
- Publication type:
- Article
Efficacy and Safety of Trametinib in Non‐V600 BRAF Mutant Melanoma: A Phase II Study.
- Published in:
- Oncologist, 2021, v. 26, n. 9, p. 731, doi. 10.1002/onco.13795
- By:
- Publication type:
- Article
Hybrid Capture‐Based Genomic Profiling Identifies BRAF V600 and Non‐V600 Alterations in Melanoma Samples Negative by Prior Testing.
- Published in:
- Oncologist, 2019, v. 24, n. 5, p. 657, doi. 10.1634/theoncologist.2018-0271
- By:
- Publication type:
- Article
Clinical Activity of Ipilimumab in Acral Melanoma: A Retrospective Review.
- Published in:
- Oncologist, 2015, v. 20, n. 6, p. 648, doi. 10.1634/theoncologist.2014-0468
- By:
- Publication type:
- Article
Adverse Events Associated With Immune Checkpoint Inhibitors-Reply.
- Published in:
- 2019
- By:
- Publication type:
- letter
Immune Checkpoint Inhibitor Toxicity in 2018.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Update on the Targeted Therapy of Melanoma.
- Published in:
- Current Treatment Options in Oncology, 2013, v. 14, n. 2, p. 280, doi. 10.1007/s11864-013-0226-8
- By:
- Publication type:
- Article
Health care utilization and steroid-refractory toxicities from immune checkpoint inhibitors.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Patient-centered engagement and symptom/toxicity monitoring in the new era of tumor next-generation sequencing and immunotherapy: The OncoTool and OncoPRO platforms.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Melanoma: What do all the mutations mean?
- Published in:
- 2018
- By:
- Publication type:
- journal article
Clinical outcomes in metastatic uveal melanoma treated with PD-1 and PD-L1 antibodies.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Phase 2 study of sunitinib in patients with metastatic mucosal or acral melanoma.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Two phase 2 trials of the novel Akt inhibitor perifosine in patients with advanced renal cell carcinoma after progression on vascular endothelial growth factor-targeted therapy.
- Published in:
- Cancer (0008543X), 2012, v. 118, n. 24, p. 6055, doi. 10.1002/cncr.27668
- By:
- Publication type:
- Article
A phase 2 trial of complete resection for stage IV melanoma: results of Southwest Oncology Group Clinical Trial S9430.
- Published in:
- 2011
- By:
- Publication type:
- journal article
A phase 2 trial of complete resection for stage IV melanoma.
- Published in:
- Cancer (0008543X), 2011, v. 117, n. 20, p. 4740, doi. 10.1002/cncr.26111
- By:
- Publication type:
- Article
Phase 2 Trial of Combination Thalidomide Plus Temozolomide in Patients With Metastatic Malignant Melanoma: Southwest Oncology Group S0508.
- Published in:
- Cancer (0008543X), 2010, v. 116, n. 2, p. 424, doi. 10.1002/cncr.24739
- By:
- Publication type:
- Article
Combination Targeted Therapy in Advanced Renal Cell Carcinoma.
- Published in:
- Cancer (0008543X), 2009, v. 115, n. 10, p. 2368, doi. 10.1002/cncr.24234
- By:
- Publication type:
- Article
Innovations and Challenges in Renal Cancer: Summary Statement From the Third Cambridge Conference.
- Published in:
- 2009
- By:
- Publication type:
- Proceeding
CUSTOM-SEQ: a prototype for oncology rapid learning in a comprehensive EHR environment.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Spindle cell squamous carcinoma during BRAF inhibitor therapy for advanced melanoma: an aggressive secondary neoplasm of undetermined biologic potential.
- Published in:
- 2014
- By:
- Publication type:
- journal article
Spindle Cell Squamous Carcinoma During BRAF Inhibitor Therapy for Advanced Melanoma: An Aggressive Secondary Neoplasm of Undetermined Biologic Potential.
- Published in:
- JAMA Dermatology, 2014, v. 150, n. 5, p. 575, doi. 10.1001/jamadermatol.2013.7784
- By:
- Publication type:
- Article
Therapy targeted at vascular endothelial growth factor in metastatic renal cell carcinoma: biology, clinical results and future development.
- Published in:
- BJU International, 2005, v. 96, n. 3, p. 286, doi. 10.1111/j.1464-410X.2005.05616.x
- By:
- Publication type:
- Article
Nivolumab in melanoma: latest evidence and clinical potential.
- Published in:
- Therapeutic Advances in Medical Oncology, 2015, v. 7, n. 2, p. 97, doi. 10.1177/1758834014567469
- By:
- Publication type:
- Article
Kidney Cancer: Recent Advances in Diagnosis and Management.
- Published in:
- AUANews, 2008, v. 13, p. 7
- By:
- Publication type:
- Article
Severe eosinophilia and hepatocellular carcinoma: An unusual association.
- Published in:
- Diagnostic Cytopathology, 1995, v. 13, n. 2, p. 151, doi. 10.1002/dc.2840130215
- By:
- Publication type:
- Article
CORRESPONDENCE.
- Published in:
- 2005
- By:
- Publication type:
- Letter
Sunlight and Reduced Risk of Cancer: Is The Real Story Vitamin D?
- Published in:
- JNCI: Journal of the National Cancer Institute, 2005, v. 97, n. 3, p. 161, doi. 10.1093/jnci/dji047
- By:
- Publication type:
- Article
Identifying treatment options for BRAF<sup>V600</sup> wild-type metastatic melanoma: A SU2C/MRA genomics-enabled clinical trial.
- Published in:
- PLoS ONE, 2021, v. 16, n. 4, p. 1, doi. 10.1371/journal.pone.0248097
- By:
- Publication type:
- Article
Temozolomide, thalidomide, and whole brain radiation therapy for patients with brain metastasis from metastatic melanoma: a phase II Cytokine Working Group study.
- Published in:
- 2008
- By:
- Publication type:
- journal article
Multicenter Phase II trial of high‐dose imatinib mesylate in metastatic melanomaPresented in part as a poster (abstract 2865) at the Annual Meeting of the American Society of Clinical Oncology; Chicago, Illinois, May 31–June 3, 2003.: Significant toxicity with no clinical efficacy
- Published in:
- Cancer (0008543X), 2006, v. 106, n. 9, p. 2005
- By:
- Publication type:
- Article
Immunomodulatory effects of high-dose and low-dose interferon alpha2b in patients with high-risk resected melanoma: the E2690 laboratory corollary of intergroup adjuvant trial E1690.
- Published in:
- 2002
- By:
- Publication type:
- journal article
Induction of specific T cell immunity in patients with prostate cancer by vaccination with PSA146–154 peptide.
- Published in:
- Cancer Immunology, Immunotherapy, 2006, v. 55, n. 9, p. 1033, doi. 10.1007/s00262-005-0090-x
- By:
- Publication type:
- Article
Induction of Tc2 cells with specificity for prostate-specific antigen from patients with hormone-refractory prostate cancer.
- Published in:
- Cancer Immunology, Immunotherapy, 2002, v. 51, n. 5, p. 263, doi. 10.1007/s00262-002-0281-7
- By:
- Publication type:
- Article
RAF inhibitor resistance is mediated by dimerization of aberrantly spliced BRAF(V600E).
- Published in:
- Nature, 2011, v. 480, n. 7377, p. 387, doi. 10.1038/nature10662
- By:
- Publication type:
- Article
Melanomas acquire resistance to B-RAF(V600E) inhibition by RTK or N-RAS upregulation.
- Published in:
- Nature, 2010, v. 468, n. 7326, p. 973, doi. 10.1038/nature09626
- By:
- Publication type:
- Article
Impact of MET expression on outcome in BRAF<sup>V600E/K</sup> advanced melanoma.
- Published in:
- Histopathology, 2013, v. 63, n. 3, p. 351, doi. 10.1111/his.12169
- By:
- Publication type:
- Article
Neurological applications of belzutifan in von Hippel-Lindau disease.
- Published in:
- Neuro-Oncology, 2023, v. 25, n. 5, p. 827, doi. 10.1093/neuonc/noac234
- By:
- Publication type:
- Article
Endocrine side effects of immune checkpoint inhibitors.
- Published in:
- Frontiers in Endocrinology, 2023, p. 1, doi. 10.3389/fendo.2023.1157805
- By:
- Publication type:
- Article
Antibody targeting tumor-derived soluble NKG2D ligand sMIC reprograms NK cell homeostatic survival and function and enhances melanoma response to PDL1 blockade therapy.
- Published in:
- Journal of Hematology & Oncology, 2020, v. 13, n. 1, p. 1, doi. 10.1186/s13045-020-00896-0
- By:
- Publication type:
- Article
Nivolumab versus everolimus in patients with advanced renal cell carcinoma: Updated results with long-term follow-up of the randomized, open-label, phase 3 CheckMate 025 trial.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Oral health in oncology: impact of immunotherapy.
- Published in:
- 2015
- By:
- Publication type:
- Letter
Melanoma-specific MHC-II expression represents a tumour-autonomous phenotype and predicts response to anti-PD-1/PD-L1 therapy.
- Published in:
- Nature Communications, 2016, v. 7, n. 1, p. 10582, doi. 10.1038/ncomms10582
- By:
- Publication type:
- Article
Routine Multiplex Mutational Profiling of Melanomas Enables Enrollment in Genotype-Driven Therapeutic Trials.
- Published in:
- PLoS ONE, 2012, v. 7, n. 4, p. 1, doi. 10.1371/journal.pone.0035309
- By:
- Publication type:
- Article
Inside life of melanoma cell signaling, molecular insights, and therapeutic targets.
- Published in:
- Current Oncology Reports, 2009, v. 11, n. 5, p. 405, doi. 10.1007/s11912-009-0054-y
- By:
- Publication type:
- Article